Stay updated on Long-term Safety of Dupilumab in Pediatric AD Clinical Trial
Sign up to get notified when there's something new on the Long-term Safety of Dupilumab in Pediatric AD Clinical Trial page.

Latest updates to the Long-term Safety of Dupilumab in Pediatric AD Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe page's revision was updated to v3.6.5 and the previous v3.6.4 was removed, reflecting a small metadata update to the revision history.SummaryDifference0.0%

- Check21 days agoNo Change Detected
- Check29 days agoChange DetectedRevision: v3.6.4 is now shown, replacing the previous Revision: v3.6.3. This indicates a new page revision.SummaryDifference0.0%

- Check50 days agoChange DetectedThe page revision metadata was updated from v3.6.2 to v3.6.3, reflecting a newer version of the page.SummaryDifference0.0%

- Check57 days agoChange DetectedThe page's revision tag was updated to v3.6.2 and the older tag removed, indicating a backend update. It does not change the visible study content or user-facing information.SummaryDifference0.0%

- Check71 days agoChange DetectedNew help/navigation sections were added (How to Read a Study Record, Common Questions, How to Join a Study) and a recruitment note ('No longer looking for participants'), while the 'Intervention / Treatment' heading was replaced with 'Intervention/Treatment' and the 'Revision: v3.5.5' tag was removed.SummaryDifference0.2%

- Check79 days agoChange DetectedThe page now shows Revision: v3.5.5, replacing the previous Revision: v3.5.4. This indicates a minor software/content rendering update for the study page.SummaryDifference0.0%

Stay in the know with updates to Long-term Safety of Dupilumab in Pediatric AD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Long-term Safety of Dupilumab in Pediatric AD Clinical Trial page.